These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8342553)

  • 1. Ciprofloxacin-induced neutropenia and erythema multiforme.
    Imrie K; Gold W; Salit I; Keating A
    Am J Hematol; 1993 Jun; 43(2):159-60. PubMed ID: 8342553
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute renal failure due to ciprofloxacin.
    Allon M; Lopez EJ; Min KW
    Arch Intern Med; 1990 Oct; 150(10):2187-9. PubMed ID: 2222106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of erythema multiforme major following administration of ciprofloxacin ophthalmic drops.
    Arnold M; Wilkerson M
    Dermatol Online J; 2017 Oct; 23(10):. PubMed ID: 29469784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A suspected case of codeine-induced erythema multiforme.
    Ponte CD
    Drug Intell Clin Pharm; 1983 Feb; 17(2):128-30. PubMed ID: 6825567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dapsone-induced erythema multiforme with neutropenia in a patient with linear IgA dermatosis: case report and review of the literature.
    Urosevic-Maiwald M; Kerl K; Harr T; Bogdan Allemann I
    Int J Dermatol; 2013 Nov; 52(11):1369-71. PubMed ID: 23829595
    [No Abstract]   [Full Text] [Related]  

  • 6. Multidrug-induced erythema multiforme.
    Isik SR; Karakaya G; Erkin G; Kalyoncu AF
    J Investig Allergol Clin Immunol; 2007; 17(3):196-8. PubMed ID: 17583109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ciprofloxacin in the treatment of bronchopulmonary infections].
    Girbino G; Giacobbe G; Quattrone G; Fiorello G
    Riv Eur Sci Med Farmacol; 1990; 12(4-5):259-63. PubMed ID: 2103966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ciprofloxacin in the treatment of respiratory infections. Analysis of an Italian series].
    Maggiolo F; Bianchi W; Ohnmeiss H
    G Ital Chemioter; 1988; 35(1-3):39-44. PubMed ID: 3256511
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical efficacy of ciprofloxacin in the treatment of patients with respiratory tract infections in Japan.
    Kobayashi H
    Am J Med; 1987 Apr; 82(4A):169-73. PubMed ID: 3555031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ciprofloxacin in the treatment of urinary and respiratory tract infections in patients with chronic liver disease.
    Galante D; Esposito S; Barba D; Giusti G
    Chemioterapia; 1986 Oct; 5(5):322-6. PubMed ID: 3791479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ciprofloxacin-induced neutropenia: an infrequent adverse effect].
    Pons M; del Blanco J; Mateo L; Juanola X
    Med Clin (Barc); 1991 Mar; 96(8):318-9. PubMed ID: 2041408
    [No Abstract]   [Full Text] [Related]  

  • 12. Ceftazidime in the treatment of lower respiratory tract infection.
    Peirce TH; Vig SJ; Ingram PM
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():21-5. PubMed ID: 6352621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ciprofloxacin.
    Med Lett Drugs Ther; 1988 Jan; 30(758):11-3. PubMed ID: 3277024
    [No Abstract]   [Full Text] [Related]  

  • 14. Ciprofloxacin-associated Achilles tendon rupture in a hemodialysis patient.
    Malaguti M; Triolo L; Biagini M
    J Nephrol; 2001; 14(5):431-2. PubMed ID: 11730281
    [No Abstract]   [Full Text] [Related]  

  • 15. Randomized study of intravenous/oral ciprofloxacin versus ceftazidime in the treatment of hospital and nursing home patients with lower respiratory tract infections.
    Trenholme GM; Schmitt BA; Spear J; Gvazdinskas LC; Levin S
    Am J Med; 1989 Nov; 87(5A):116S-118S. PubMed ID: 2686411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with ciprofloxacin: analysis of a multicenter study.
    Karimi K
    Indiana Med; 1990 Apr; 83(4):266-9. PubMed ID: 2185309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy, safety and pharmacokinetics of intravenous ciprofloxacin in patients with lower respiratory tract infections.
    Ohmichi M; Hiraga Y
    J Int Med Res; 1999; 27(6):297-304. PubMed ID: 10726239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of intravenous ciprofloxacin in patients with nosocomial lower respiratory tract infections. Impact of plasma concentrations, organism, minimum inhibitory concentration, and clinical condition on bacterial eradication.
    Peloquin CA; Cumbo TJ; Nix DE; Sands MF; Schentag JJ
    Arch Intern Med; 1989 Oct; 149(10):2269-73. PubMed ID: 2508586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythema multiforme due to pyrazinamide.
    Perdu D; Lavaud F; Prévost A; Deschamps F; Cambie MP; Bongrain E; Barhoum K; Kalis B
    Allergy; 1996 May; 51(5):340-2. PubMed ID: 8836340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled, comparative study of ciprofloxacin versus ampicillin in treatment of bacterial respiratory tract infections.
    Wollschlager CM; Raoof S; Khan FA; Guarneri JJ; LaBombardi V; Afzal Q
    Am J Med; 1987 Apr; 82(4A):164-8. PubMed ID: 3555030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.